Disease measures in evaluating the effect of anti-TNF therapy and predicting clinical outcome.
Tutuncu
Z
Z
Bansal
C
C
Kavanaugh
A
A
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy*; D006801:Humans; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha